Clinical Trial Update: Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients With Extreme Short Stature [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a luteinizing hormone-releasing hormone analog in pubertal patients with extreme short stature has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dwarfism
• Growth Disorder

Drugs mentioned

• Luteinizing hormone-releasing hormone analog (LHRHa) (Luteinizing hormone-releasing hormone agonist)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Dwarfism, Growth Disorder | Phase 2 | Status: COMPLETED